Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00671) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Endoxifen
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 3 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10090750"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 2C8 (CYP2C8) | DME Info | Homo sapiens | [1] | |||
| Cytochrome P450 2C9 (CYP2C9) | DME Info | Homo sapiens | [1] | |||
| DME(s) Induced by This Xenobiotics | ||||||
| Cytochrome P450 1A1 (CYP1A1) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes. Arch Toxicol. 2018 Mar;92(3):1099-1112. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.